C000265138 Holdings — Portfolio Building Block World Pharma and Biotech Index ETF
All 53 reported holdings of Portfolio Building Block World Pharma and Biotech Index ETF (C000265138) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Eli Lilly & Company | 15.20% | $144.71M |
| Johnson & Johnson | 9.66% | $91.97M |
| Abbvie, Inc. | 6.94% | $66.12M |
| Roche Holding AG | 5.05% | $48.07M |
| Merck & Company, Inc. | 5.04% | $47.96M |
| Amgen, Inc. | 4.64% | $44.14M |
| Novartis AG | 4.47% | $42.61M |
| Astrazeneca PLC | 3.90% | $37.10M |
| Gilead Sciences, Inc. | 3.77% | $35.92M |
| Novo Nordisk A/s | 3.51% | $33.42M |
| Pfizer, Inc. | 3.33% | $31.67M |
| Bristol-Myers Squibb Company | 3.11% | $29.61M |
| Vertex Pharmaceuticals, Inc. | 2.82% | $26.84M |
| Gsk PLC | 2.26% | $21.51M |
| Sanofi SA | 2.17% | $20.67M |
| Regeneron Pharmaceuticals, Inc. | 1.79% | $17.01M |
| Bayer AG | 1.27% | $12.07M |
| Takeda Pharmaceutical Company Ltd. | 1.25% | $11.91M |
| Argenx SE | 1.24% | $11.81M |
| Csl Ltd. | 1.11% | $10.57M |
| Teva Pharmaceutical Industries Ltd. | 0.96% | $9.13M |
| Natera, Inc. | 0.85% | $8.06M |
| Sandoz Group AG | 0.78% | $7.38M |
| Revolution Medicines, Inc. | 0.77% | $7.37M |
| Zoetis, Inc. | 0.76% | $7.21M |
| Illumina, Inc. | 0.72% | $6.90M |
| Ucb SA | 0.72% | $6.86M |
| Biogen, Inc. | 0.70% | $6.67M |
| Otsuka Holdings Company Ltd. | 0.67% | $6.36M |
| Chugai Pharmaceutical Co. Ltd. | 0.64% | $6.05M |
| Haleon PLC | 0.64% | $6.05M |
| Alnylam Pharmaceuticals, Inc. | 0.63% | $6.03M |
| Daiichi Sankyo Company Ltd. | 0.62% | $5.89M |
| Incyte Corp. | 0.56% | $5.36M |
| Astellas Pharma, Inc. | 0.56% | $5.33M |
| United Therapeutics Corp. | 0.51% | $4.87M |
| Royalty Pharma PLC | 0.51% | $4.86M |
| Merck Kgaa | 0.50% | $4.72M |
| Insmed, Inc. | 0.48% | $4.61M |
| Viatris, Inc. | 0.47% | $4.51M |
| Moderna, Inc. | 0.45% | $4.29M |
| Genmab A/s | 0.40% | $3.79M |
| Neurocrine Biosciences, Inc. | 0.39% | $3.70M |
| Roivant Sciences Ltd. | 0.38% | $3.64M |
| Jazz Pharmaceuticals PLC | 0.36% | $3.43M |
| Dreyfus Trsry Securities | 0.34% | $3.26M |
| Elanco Animal Health, Inc. | 0.31% | $2.97M |
| Shionogi & Co. Ltd. | 0.31% | $2.93M |
| Exelixis, Inc. | 0.30% | $2.90M |
| Bridgebio Pharma, Inc. | 0.27% | $2.61M |
| Galderma Group AG | 0.27% | $2.58M |
| Biomarin Pharmaceutical, Inc. | 0.27% | $2.57M |
| Ionis Pharmaceuticals, Inc. | 0.18% | $1.76M |
C000265138 overview: performance, fees, allocation and SEC filings